Similar articles for PMID: 27349273

Year	Number of Results
1989	1
1996	1
1997	1
1998	2
2001	2
2003	1
2005	2
2006	2
2007	1
2008	2
2009	9
2010	2
2011	4
2012	3
2013	6
2014	6
2015	7
2016	8
2017	2
2018	3
2019	1
2020	2
2021	5
2022	4
2023	4
2024	0

1

Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.

Malandrino P, Russo M, Regalbuto C, Pellegriti G, Moleti M, Caff A, Squatrito S, Vigneri R. Malandrino P, et al. Thyroid. 2016 Sep;26(9):1285-92. doi: 10.1089/thy.2016.0168. Epub 2016 Jul 22. Thyroid. 2016. PMID: 27349273

2

Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.

Russo M, Malandrino P, Moleti M, Vermiglio F, Violi MA, Marturano I, Minaldi E, Vigneri R, Pellegriti G, Regalbuto C. Russo M, et al. J Endocrinol Invest. 2017 Nov;40(11):1235-1241. doi: 10.1007/s40618-017-0688-9. Epub 2017 May 20. J Endocrinol Invest. 2017. PMID: 28528434

3

Prognostic importance of sclerosing variant in papillary thyroid carcinoma.

Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E. Falvo L, et al. Am Surg. 2006 May;72(5):438-44. Am Surg. 2006. PMID: 16719201

4

A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.

Regalbuto C, Malandrino P, Tumminia A, Le Moli R, Vigneri R, Pezzino V. Regalbuto C, et al. Thyroid. 2011 Apr;21(4):383-9. doi: 10.1089/thy.2010.0331. Thyroid. 2011. PMID: 21309722

5

Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.

Kazaure HS, Roman SA, Sosa JA. Kazaure HS, et al. Ann Surg Oncol. 2012 Jun;19(6):1874-80. doi: 10.1245/s10434-011-2129-x. Epub 2011 Nov 8. Ann Surg Oncol. 2012. PMID: 22065195

6

Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.

Feng J, Shen F, Cai W, Gan X, Deng X, Xu B. Feng J, et al. Endocrine. 2018 Sep;61(3):499-505. doi: 10.1007/s12020-018-1644-y. Epub 2018 Jun 16. Endocrine. 2018. PMID: 29909599

7

Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study.

Chereau N, Giudicelli X, Pattou F, Lifante JC, Triponez F, Mirallié E, Goudet P, Brunaud L, Trésallet C, Tissier F, Leenhardt L, du Montcel ST, Menegaux F. Chereau N, et al. J Clin Endocrinol Metab. 2016 Dec;101(12):4603-4610. doi: 10.1210/jc.2016-2341. Epub 2016 Sep 14. J Clin Endocrinol Metab. 2016. PMID: 27626975

8

Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.

Akaishi J, Sugino K, Kameyama K, Masaki C, Matsuzu K, Suzuki A, Uruno T, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Shimizu K, Ito K. Akaishi J, et al. World J Surg. 2015 Jul;39(7):1728-35. doi: 10.1007/s00268-015-3021-9. World J Surg. 2015. PMID: 25743484

9

Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Thompson LD, Wieneke JA, Heffess CS. Thompson LD, et al. Endocr Pathol. 2005 Winter;16(4):331-48. doi: 10.1385/ep:16:4:331. Endocr Pathol. 2005. PMID: 16627920

10

Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.

Vuong HG, Kondo T, Pham TQ, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R. Vuong HG, et al. Eur J Endocrinol. 2017 Apr;176(4):433-441. doi: 10.1530/EJE-16-0863. Eur J Endocrinol. 2017. PMID: 28183787 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year